GTR 110611271
Tenders Are Invited For Pharmaceutical Products – Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Medicines With The Active Ingredient Palonosetron (Atc Code: A04aa05).
ICB — International Competitive Bid
Closes Feb 26, 2028
Western Europe
Tender Information
GTR Reference
110611271
Tendering Authority
Subscribe to view
Tender No
187809-2026
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Pharmaceutical Products – Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Medicines With The Active Ingredient Palonosetron (Atc Code: A04aa05).
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Western Europe
Political Region
European Union,G20
Last Date of Bid Submission
26-02-2028
Work Detail
Pharmaceutical Products – Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Medicines With The Active Ingredient Palonosetron (Atc Code: A04aa05).. Conclusion Of A Non-Exclusive Discount Contract In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Palonosetron (Atc Code: A04aa05) Within The Period From May 1St, 2026 To April 30Th, 2028 With The Possibility Of Concluding The Contract At Any Time During The Term (“Open-House Model”). Description: The Aok Lower Saxony Offers The Active Ingredient Palonosetron (Atc Code: A04aa05). The Health Insurance Company Offers Discount Contracts To All Interested Pharmaceutical Companies Without A Selection Decision For The Period Up To The Entry Into Force Of Exclusive Contracts As A Result Of A Formal Award Procedure In Accordance With The Regulations Of Part 4 Of The Gwb. The Contracts Are Concluded As Part Of An “Open-House Model” And Are Not Exclusive; Contracts With All Market Participants (Pharmaceutical Companies) Are Desired By Aok Niedersachsen. In The Open-House Model, Uniform Conditions Apply To All Participants. Contract Contents, Conditions And Access Procedures Are Uniform - Individual Negotiations Are Generally Not Carried Out. The Contract Terms Are A Maximum Of Twenty-Four Months; The Earliest Contract Start Date Is May 1, 2026. All Contracts End On April 30, 2028 At The Latest, Regardless Of The Date Of Conclusion Of The Respective Contract. Joining Or Concluding A Contract Can Take Place On The First Of Each Month Within The Twenty-Four Month Period. There Is A Right Of Termination Six Weeks To The End Of The Month. The Aok Lower Saxony. The Health Insurance Fund Reserves The Right To Replace The Non-Exclusive Open-House Discount Agreements With Exclusive Discount Agreements During The Contract Term. When Advertised, Exclusive Discount Contracts Come Into Force, The Open-House Contracts Will Be Terminated In Accordance With The Contractual Regulations, I.E. H. The Open House Contracts End Automatically. According To Aok Niedersachsens Experience, Exclusive Discount Agreements Usually Come Into Force Six To Eight Months After The Publication Of The Corresponding Tender Notice In The Supplement To The Official Journal Of The European Union. The Future Contractual Partners In The Open-House Model Are Requested To Regularly Consult The Supplement To The Official Journal Of The European Union Regarding These Tender Notices. Interested Pharmaceutical Companies Can Request The Contract Documents And The Contract Conditions At The Contact Address Mentioned Under I.1). Contracts For The Active Ingredient Palonosetron (Atc Code: A04aa05) Will Be Concluded For The First Time With Effect From May 1, 2026. Interested Parties Who Would Like To Become Contractual Partners On This Date Must Submit The Contractual Documents To The Address Specified In The Contractual Documents By March 31, 2026. It Depends On Access To Aok Niedersachsen. Later Contracts Are Possible During The Twenty-Four-Month Maximum Term On The First Of Each Month. Organizationally It Is A Template
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
49f85c87-9f20-4008-973a-19de8bc6ed42.html
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.